GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Equity-to-Asset

Alterola Biotech (Alterola Biotech) Equity-to-Asset

: -338.75 (As of Dec. 2023)
View and export this data going back to 2009. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Alterola Biotech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-1.36 Mil. Alterola Biotech's Total Assets for the quarter that ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Alterola Biotech's Equity-to-Asset or its related term are showing as below:

ABTI' s Equity-to-Asset Range Over the Past 10 Years
Min: -338.75   Med: -14.73   Max: 0.9
Current: -338.75

During the past 13 years, the highest Equity to Asset Ratio of Alterola Biotech was 0.90. The lowest was -338.75. And the median was -14.73.

ABTI's Equity-to-Asset is ranked worse than
100% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs ABTI: -338.75

Alterola Biotech Equity-to-Asset Historical Data

The historical data trend for Alterola Biotech's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Mar22 Mar23
Equity-to-Asset
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -13.53 -21.53 0.90 0.82

Alterola Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.82 0.82 -4.07 -338.75

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alterola Biotech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alterola Biotech Equity-to-Asset Distribution

For the Drug Manufacturers industry and Healthcare sector, Alterola Biotech's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Alterola Biotech's Equity-to-Asset falls into.



Alterola Biotech Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Alterola Biotech's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=10.096/12.377
=

Alterola Biotech's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-1.355/0.004
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alterola Biotech  (OTCPK:ABTI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Alterola Biotech Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Alterola Biotech's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Alterola Biotech (Alterola Biotech) Business Description

Traded in Other Exchanges
N/A
Address
47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR
Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.
Executives
Bright Green Corp 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301